Douglas A. Levine
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)Memorial Sloan Kettering Cancer Center(US)The University of Texas MD Anderson Cancer Center(US)NYU Langone Health(US)Merck Institute for Science Education(US)New York University(US)
Publications by Year
Research Areas
Ovarian cancer diagnosis and treatment, Cancer Genomics and Diagnostics, Cancer-related molecular mechanisms research, BRCA gene mutations in cancer, Endometrial and Cervical Cancer Treatments
Most-Cited Works
- → Inferring tumour purity and stromal and immune cell admixture from expression data(2013)10,535 cited
- → An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics(2018)3,844 cited
- → OncoKB: A Precision Oncology Knowledge Base(2017)2,642 cited
- → Absolute quantification of somatic DNA alterations in human cancer(2012)2,192 cited
- → Rethinking ovarian cancer: recommendations for improving outcomes(2011)1,500 cited
- → Evaluating cell lines as tumour models by comparison of genomic profiles(2013)1,484 cited
- → Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer